ASX:EMV EMVision Medical Devices (EMV) Stock Price, News & Analysis → The new masters of energy (From Porter & Company) (Ad) Free EMV Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume192,157 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get EMVision Medical Devices alerts: Email Address Ad Porter & CompanyTrump’s arrest is phase oneIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now. About EMVision Medical Devices Stock (ASX:EMV)EMVision Medical Devices Ltd engages in the research, development, and commercialization of imaging and diagnostic technology products. It develops a portable brain scanner for stroke diagnosis and monitoring, as well as other medical imaging needs. The company was incorporated in 2017 and is based in Macquarie Park, Australia.Read More Ad Porter & CompanyTrump’s arrest is phase oneIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now. EMV Stock News HeadlinesMay 27, 2024 | finance.yahoo.comEMVision’s stroke diagnosis AI algorithms show promise in trialMay 26, 2024 | msn.comASX Health Stocks: EMV’s AI algo shows promise, and Telix submits new FDA applicationMay 23, 2024 | markets.businessinsider.comBIOMEDevice Rebrands as MEDevice, Informa Markets - Engineering's Dedicated Platform to Medical Device InnovationMay 23, 2024 | msn.comGovt revisiting the standards for medical devices considering evolving technology in medical sciencesMay 22, 2024 | reuters.comMedical device company to pay $42 million to resolve US lead-testing defect chargesMay 19, 2024 | dallasnews.comThe Motley Fool: There are dividends in medical devicesMay 8, 2024 | msn.comFlexible electronic device may offer a new approach to the treatment of spinal injuriesMay 8, 2024 | msn.comExperimental device yields fresh hope for patients with spinal cord injuriesMay 8, 2024 | msn.comNew device that emits magnetic field may offer hope for treating depressionMay 8, 2024 | msn.comSamsung Acquires French AI Firm Sonio to Advance Medical Diagnostic SystemsMay 8, 2024 | msn.comNovel head-mounted device shows promise in alleviating depression symptomsMay 7, 2024 | msn.comKKR agrees to acquire Indian medical devices company HealthiumMay 6, 2024 | bloomberg.comKKR to Acquire Indian Medical Device Maker Healthium From ApaxApril 18, 2024 | msn.comThis EMS Device Tightens My Jawline in 10 MinutesApril 16, 2024 | msn.comJohnson & Johnson's bet on heart devices boosted sales — but it still missed analysts' expectationsApril 16, 2024 | appleinsider.comFuture Apple Vision Pro could help the user get life-saving medical adviceApril 5, 2024 | msn.comJohnson & Johnson to Buy Shockwave Medical for $13.1 Billion. It’s a Cardio Health Play.April 3, 2024 | ft.com‘Made in Australia’ drive aims to shift economy from ‘world’s quarry’ labelApril 1, 2024 | msn.comConcept Medical Receives US FDA IDE Approval For MagicTouch AVF To Improve Haemodialysis TreatmentMarch 26, 2024 | msn.comFDA May Ban Electroshock Devices Used on Some Psychiatric PatientsMarch 20, 2024 | wsj.comEMvision Medical Devices Ltd.March 15, 2024 | finance.yahoo.comEMVision Medical Devices Ltd's (ASX:EMV) largest shareholders are retail investors with 54% ownership, insiders own 23%March 7, 2024 | msn.comMedical Guardian vs. Lively Medical Alert SystemsMarch 6, 2024 | msn.comBest Affordable Medical Alert SystemsMarch 4, 2024 | msn.comResearchers develop electron beam accelerator to sterilize medical equipmentSee More Headlines Receive EMV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for EMVision Medical Devices and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/26/2019Today6/07/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:EMV CUSIPN/A CIKN/A Webwww.emvision.com.au Phone61 2 8667 5337FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,220,000.00 Net Margins-37.17% Pretax MarginN/A Return on Equity-47.66% Return on Assets-16.10% Debt Debt-to-Equity Ratio52.07 Current Ratio1.91 Quick Ratio8.04 Sales & Book Value Annual Sales$8.68 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow8.47 Book ValueA$0.07 per share Price / BookN/AMiscellaneous Outstanding Shares85,420,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.61 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Scott KirklandCEO, MD & Executive DirectorMs. Emma Waldon (Age 48)CFO & Company Secretary Ms. Forough KhandanChief Technology OfficerProf. Stuart Crozier B.E.M.Sc., Ph.D., Chairman of Clinical Advisory Board & Chief Scientific OfficerMr. Robert TillerHead of DesignDr. Konstanty BialkowskiHead of Tech DevelopmentDr. Christian WightHead of Regulatory AffairsMore ExecutivesKey Competitors4DMedicalASX:4DXAdheriumASX:ADRAinosNASDAQ:AIMDWAllegra Medical TechnologiesASX:AMTAnalyticaASX:ALTView All CompetitorsInsidersPhillip DuboisSold 500,000 sharesTotal: $850,000.00 ($1.70/share) EMV Stock Analysis - Frequently Asked Questions How were EMVision Medical Devices' earnings last quarter? EMVision Medical Devices Ltd (ASX:EMV) released its quarterly earnings data on Tuesday, February, 26th. The company reported ($4.47) earnings per share (EPS) for the quarter. EMVision Medical Devices had a negative trailing twelve-month return on equity of 47.66% and a negative net margin of 37.17%. This page (ASX:EMV) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EMVision Medical Devices Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Share EMVision Medical Devices With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.